A Multisite Pilot Study of Extended-Release Injectable Naltrexone Treatment for Previously Opioid-Dependent Parolees and Probationers
- 1 January 2012
- journal article
- research article
- Published by SAGE Publications in Substance Abuse
- Vol. 33 (1) , 48-59
Abstract
A feasibility study was conducted to pilot test the ability of 5 sites to recruit, treat, and retain opioid-dependent offenders in a trial of extended-release injectable naltrexone (XR-NTX). The participants, 61 previously opioid-dependent individuals under legal supervision in the community, received up to 6 monthly injections of Depotrex brand naltrexone and completed a 6-month follow-up interview. Six-month outcomes showed that those who completed treatment had significantly fewer opioid-positive urines and were less likely to have been incarcerated than those who had not completed treatment. The findings indicate that XR-NTX holds promise as a feasible, effective treatment option for opioid-dependent offenders.Keywords
This publication has 39 references indexed in Scilit:
- A Randomized Trial of Oral Naltrexone for Treating Opioid‐Dependent OffendersThe American Journal on Addictions, 2010
- Why don’t out-of-treatment individuals enter methadone treatment programmes?International Journal of Drug Policy, 2010
- Methadone and buprenorphine prescribing and referral practices in US prison systems: Results from a Nationwide SurveyDrug and Alcohol Dependence, 2009
- An Integrated Drug Counseling and Employment Intervention for Methadone ClientsJournal of Psychoactive Drugs, 2009
- Attitudes Toward Buprenorphine and Methadone Among Opioid‐Dependent IndividualsThe American Journal on Addictions, 2008
- The Impact of Modern Neuroscience on Treatment of Parolees: Ethical Considerations in Using Pharmacology to Prevent Addiction RelapseSSRN Electronic Journal, 2008
- The effectiveness of outreach case management in re-enrolling discharged methadone patientsDrug and Alcohol Dependence, 2006
- Naltrexone for probationers and paroleesJournal of Substance Abuse Treatment, 2006
- Single‐ and Multiple‐Dose Pharmacokinetics of Long‐acting Injectable NaltrexoneAlcohol, Clinical and Experimental Research, 2006
- Four‐year follow‐up of imprisoned male heroin users and methadone treatment: mortality, re‐incarceration and hepatitis C infectionAddiction, 2005